(Q35826343)

10 August 2017

1 reference

title

How effective are the usual treatments for ulcerative colitis? (English)

1 reference

10 August 2017

Bebb JR

1

1 reference

10 August 2017

Scott BB

series ordinal

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

Alimentary Pharmacology & Therapeutics

10 August 2017

published in

1 reference

10 August 2017

volume

20

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

143-149

1 reference

City reacts negatively as GlaxoSmithKline announces plans for new drugs

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02018.X

Intensive intravenous regimen for severe attacks of ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02018.X

Further experience in the treatment of severe attacks of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02018.X

Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02018.X

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02018.X

Review article: the data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02018.X

10.1111/J.1365-2036.2004.02018.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference